{
    "name": "naphazoline/pheniramine ophthalmic",
    "comment": "OTC",
    "other_names": [
        "Naphcon-A",
        "Opcon-A",
        "Visine-A"
    ],
    "classes": [
        "Antihistamines/Decongestants",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/naphcon-a-opcon-a-naphazoline-pheniramine-ophthalmic-999604",
    "pregnancy": {
        "common": [
            "There are no or limited amount of data from use of topical ophthalmic naphazoline or pheniramine in pregnant women; animal studies are insufficient with respect to reproductive toxicity"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown whether topical naphazoline/metabolites are excreted in human milk; however, a risk to suckling child cannot be excluded"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "For external use only",
                "Do not use if solution becomes cloudy",
                "Ask healthcare professional if diagnosed with narrow-angle glaucoma, hypertension, heart disease, or benign prostatic hypertrophy",
                "Treatment may cause pupils to become enlarged temporarily, causing light sensitivity",
                "Overuse may cause more eye redness",
                "Remove contact lenses before using; wait 15 minutes after dosing to apply them back on",
                "Do not touch tip of container to any surface to avoid contamination",
                "Replace cap after each use",
                "Ask healthcare practitioner if feel eye pain, changes in vision occur, or redness or irritation of the eyes gets worse or lasts more than 72 hours",
                "Keep out of reach of children; if swallowed, get medical help or contact a Poison Control Center right away; accidental swallowing by infants and children may lead to coma and marked reduction in body temperature"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Stinging",
            "percent": null
        },
        {
            "name": "tingling sensation upon instillation",
            "percent": null
        },
        {
            "name": "Mydriasis",
            "percent": null
        },
        {
            "name": "Ocular erythema",
            "percent": null
        }
    ]
}